Infusion-related reactions to infliximab (remicade®) in patients with rheumatoid arthritis:: Relationship to dose, anti-histamine pre-treatment and infusion number

被引：0
|
作者：
Wasserman, MJ [1 ]
Weber, DA [1 ]
Guthrie, JA [1 ]
Mitroi, E [1 ]
Bykerk, V [1 ]
Lee, P [1 ]
Keystone, EC [1 ]
机构：
[1] Univ Toronto, Mt Sinai Hosp, Ctr Adv Therapeut, Toronto, ON M5G 1X5, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2003年 / 30卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1888 / 1888
页数：1
相关论文
共 50 条
  • [1] Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: Relationship to dose, antihistamine pretreatment, and infusion number
    Wasserman, MJ
    Weber, DA
    Guthrie, JA
    Bykerk, VP
    Lee, P
    Keystone, EC
    [J]. JOURNAL OF RHEUMATOLOGY, 2004, 31 (10) : 1912 - 1917
  • [2] Pre-treatment with Idelalisib markedly reduces Rituximab infusion-related reactions and infusion interruptions in patients with CLL
    Hallek, M.
    Hillmen, P.
    Furman, R. R.
    Coutre, S. E.
    Sharman, J. P.
    Pagel, J. M.
    Barrientos, J. C.
    Zelenetz, A. D.
    Kipps, T. J.
    Flinn, I. W.
    Ghia, P.
    Eradat, H.
    Erwin, T.
    Lamanna, N.
    Coiffier, B.
    Pettitt, A. R.
    O'Brien, S. M.
    Cheson, B. D.
    Ruppert, S.
    Kroenig, H.
    Schuster, A.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 52 - 53
  • [3] PRE-TREATMENT WITH IDELALISIB MARKEDLY REDUCES RITUXIMAB INFUSION-RELATED REACTIONS AND INFUSION INTERRUPTIONS IN PATIENTS WITH CLL
    Hillmen, P.
    Furman, R. R.
    Coutre, S. E.
    Sharman, J. P.
    Pagel, J. M.
    Barrientos, J. C.
    Zelenetz, A. D.
    Kipps, T. J.
    Flinn, I.
    Ghia, P.
    Eradat, H. A.
    Lamanna, N.
    Coiffier, B.
    Pettitt, A.
    Ye, W.
    Jahn, T. M.
    Dubowy, R.
    O'Brien, S. M.
    Hallek, M. J.
    Cheson, B. D.
    [J]. HAEMATOLOGICA, 2014, 99 : 55 - 55
  • [4] Incidence of infusion-related reactions in patients receiving infliximab.
    Buch, MH
    Bryer, D
    Fairclough, A
    ReesEvans, B
    Emery, P
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S325 - S325
  • [5] INFLIXIMAB INFUSION REACTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SPONDYLARTHROPATHIES
    Markatseli, T. E.
    Migkos, M.
    Somarakis, G.
    Voulgari, P. V.
    Drosos, A. A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 432 - 432
  • [6] Anti-infliximab antibodies in patients with an infusion-related allergic response to infliximab
    Wolbink, GJ
    De Groot, E
    Lems, WF
    Nurmohamed, MT
    Tak, PP
    Dijkmans, BAC
    Voskuyl, AE
    Aarden, L
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 179 - 179
  • [7] Rapid infusion of infliximab biosimilars and the incidence and severity of infusion-related reactions in patients with inflammatory bowel disease
    Rusch, Caroline
    Wood, Marci
    Kennedy, Amanda G.
    Tompkins, Bradley J.
    Frasca, Joseph D.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (11) : 1851 - 1857
  • [8] Incidence of infusion-related reactions in patients receiving infliximab: Recommendations for administration guidelines
    Buch, MH
    Lindsay, S
    Bryer, D
    Fairclough, A
    Rees-Evans, B
    Emery, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 285 - 285
  • [9] Predictors of infusion reactions during infliximab treatment in patients with arthritis
    Kapetanovic, Meliha C.
    Larsson, Lotta
    Truedsson, Lennart
    Sturfelt, Gunnar
    Saxne, Tore
    Geborek, Pierre
    [J]. ARTHRITIS RESEARCH & THERAPY, 2006, 8 (04)
  • [10] Predictors of infusion reactions during infliximab treatment in patients with arthritis
    Kapetanovic, Meliha C.
    Larsson, Lotta
    Truedsson, Lennart
    Sturfelt, Gunnar
    Saxne, Tore
    Geborek, Pierre
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 26 - 26
12345